These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2672436)

  • 1. Enhancement of alloimmunization: a potential hazard of GM-CSF treatment in patients with severe aplastic anemia?
    Kuentz M; Bierling P; Norolle F; Cordonnier C; Rochant H; Vernant JP
    Transfusion; 1989 Sep; 29(7):654-5. PubMed ID: 2672436
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.
    Antin JH; Smith BR; Holmes W; Rosenthal DS
    Blood; 1988 Aug; 72(2):705-13. PubMed ID: 3042046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies of granulocyte-macrophage colony stimulating factor.
    Gutterman J
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):52-3. PubMed ID: 3057645
    [No Abstract]   [Full Text] [Related]  

  • 4. [GM-CSF: its clinical administration; the treatment of aplasia].
    Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
    Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 6. GM-CSF treatment and hypokalemia.
    Viens P; Thyss A; Garnier G; Ayela P; Lagrange M; Schneider M
    Ann Intern Med; 1989 Aug; 111(3):263. PubMed ID: 2665594
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S
    N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor.
    Nimer SD; Champlin RE; Golde DW
    JAMA; 1988 Dec; 260(22):3297-300. PubMed ID: 3054191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of colony-stimulating factors in clinical practice.
    Glaspy JA; Ambersley JM
    Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic hematopoiesis following GM-CSF therapy in a patient with hairy cell leukemia.
    Lindemann A; Herrmann F; Mertelsmann R; Gamm H; Rumpelt HJ
    Leukemia; 1990 Aug; 4(8):606-7. PubMed ID: 2201835
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematopoietic growth factors: biology and clinical application.
    Gabrilove JL; Jakubowski A
    J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of growth factors in severe aplastic anaemia (SAA).
    Hinterberger W; Hoffmann S; Bettelheim P; Geissler K; Maurer D; Muhm M
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():129-30. PubMed ID: 2697425
    [No Abstract]   [Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor (GM-CSF), hypocalcemia, and hypomagnesemia.
    Potter MN; Mott MG; Oakhill A
    Ann Intern Med; 1990 May; 112(9):715. PubMed ID: 2185678
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor and vasculitis.
    Dreicer R; Schiller JH; Carbone PP
    Ann Intern Med; 1989 Jul; 111(1):91-2. PubMed ID: 2660649
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant human granulocyte-macrophage colony-stimulating factor produces fever.
    Peters WP; Shogan J; Shpall EJ; Jones RB; Kim CS
    Lancet; 1988 Apr; 1(8591):950. PubMed ID: 2895883
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of CFU-GM to increasing doses of rhGM-CSF in patients with aplastic anemia.
    Bacigalupo A; Piaggio G; Figari O; Tong J; Sogno G; Tedone E; Sette A; Ratto MR; Caciagli P; Badolati G
    Exp Hematol; 1991 Sep; 19(8):829-32. PubMed ID: 1868897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
    Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
    J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.
    Socinski MA; Cannistra SA; Elias A; Antman KH; Schnipper L; Griffin JD
    Lancet; 1988 May; 1(8596):1194-8. PubMed ID: 2897009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites.
    Farmer KL; Kurzrock R; Gutterman JU; Duvic M
    Arch Dermatol; 1990 Sep; 126(9):1243-4. PubMed ID: 2204310
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)].
    Kitamura K; Asano S; Mizoguchi H; Takaku F
    Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.